Metformin Disappoints in Two Phase 2 Lung Cancer Trials ...Middle East

Medscape - News
Although well tolerated, metformin did not improve survival when given alongside chemoradiotherapy to patients with locally advanced non-small cell lung cancer (NSCLC). Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Metformin Disappoints in Two Phase 2 Lung Cancer Trials )

Apple Storegoogle play

Also on site :



Latest News